Respiratory Medicine
Volume 104, Issue 7 , Pages 934-944 , July 2010

Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: A systematic review of the literature

  • A. Molassiotis

      Affiliations

    • School of Nursing, Midwifery & Social Work, University of Manchester, University Place, Manchester M13 9PL, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 161 3067830; fax: +44 161 306.
    • ,
  • G. Bryan

      Affiliations

    • School of Nursing, Midwifery & Social Work, University of Manchester, University Place, Manchester M13 9PL, UK
    • ,
  • A. Caress

      Affiliations

    • School of Nursing, Midwifery & Social Work, University of Manchester, University Place, Manchester M13 9PL, UK
    • ,
  • C. Bailey

      Affiliations

    • School of Health Sciences, University of Southampton, UK
    • ,
  • J. Smith

      Affiliations

    • Respiratory Research Group, School of Translational Medicine, University of Manchester, UK

Received 2 September 2009 ,Accepted 12 February 2010.

References 

  1. Davis CL. ABC of palliative care. Breathlessness, cough, and other respiratory problems. British Medical Journal. 1997 Oct 11;315(7113):931–934
  2. Irwin RS, Madison JM. The diagnosis and treatment of cough. The New England Journal of Medicine. 2000 Dec 7;343(23):1715–1721
  3. Pratter MR, Brightling CE, Boulet LP, Irwin RS. An empiric integrative approach to the management of cough: aCCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(Suppl. 1):222S–231S
  4. Dicpinigaitis PV, Tso R, Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest. 2006 Dec;130(6):1839–1843
  5. McGarvey LP, Carton C, Gamble LA, Heaney LG, Shepherd R, Ennis M, et al. Prevalence of psychomorbidity among patients with chronic cough. Cough. 2006;2:4
  6. Watson MS. Oxford handbook of palliative care. Oxford; New York: Oxford University Press; 2005;
  7. Irwin RS. Complications of cough: aCCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(Suppl. 1):54S–58S
  8. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough executive summary: aCCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(Suppl. 1):1S–23S
  9. Madison JM, Irwin RS. Pharmacotherapy of chronic cough in adults. Expert Opinion on Pharmacotherapy. 2003 Jul;4(7):1039–1048
  10. Irwin RS, Madison JM. The persistently troublesome cough. American Journal of Respiratory and Critical Care Medicine. 2002 Jun 1;165(11):1469–1474
  11. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. International Journal of Epidemiology. 2002 Feb;31(1):150–153
  12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials. 1996 Feb;17(1):1–12
  13. Ciprandi G, Buscaglia S, Catrullo A, Marchesi E, Bianchi B, Canonica GW. Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis. Annals of Allergy, Asthma and Immunology. 1995;75(2):115–120
  14. Thomas M, Sheran J, Smith N, Fonseca S, Lee AJ. AKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over study. BMC Pulmonary Medicine. 2007;7:4
  15. Evald T, Munch EP, Kok-Jensen A. Chronic non-asthmatic cough is not affected by inhaled beclomethasone dipropionate. A controlled double blind clinical trial. Allergy. 1989;44(7):510–514
  16. Malo JL, Cartier A, Cote J, Milot J, Leblanc C, Paquette L, et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. American Journal of Respiratory and Critical Care Medicine. 1996;153(3):953–960
  17. Freeman LW, Welton D. Effects of imagery, critical thinking, and asthma education on symptoms and mood state in adult asthma patients: a pilot study. Journal of the Alternative and Complementary Medicine. 2005;11(1):57–68
  18. Ribeiro M, Pereira CA, Nery LE, Beppu OS, Silva CO. High-dose inhaled beclomethasone treatment in patients with chronic cough: a randomized placebo-controlled study. Annals of Allergy, Asthma and Immunology. 2007;99(1):61–68
  19. Rouhi H, Ganji F, Nasri H. Effects of ginger on the improvement of asthma (The evaluation of its' treatmental effects), Pakistan Journal of Nutrition. 2006;5(4):373–376
  20. Aubier M, Wettenger R, Gans SJ. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 μg day−1) versus HFA-fluticasone propionate (1000 μg day−1) in patients with asthma. Respiratory Medicine. 2001;95(3):212–220
  21. Ayres JG, Simmons JL, Stampone P. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients. Respiratory Medicine. 1999 Jan;93(1):27–32
  22. Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate. British Journal of Clinical Practice. 1997 Jan–Feb;51(1):11–15
  23. Dorow P, Schiess W. The influence of ketotifen and aminophylline on the central and peripheral airways. Arzneimittelforschung. 1983;33(2):265–268
  24. Monie RD, Smith AP, Leopold D, Anderson G, Davies BH, Thomas GO. A double-blind clinical-trial of ketotifen and disodium-cromoglycate in bronchial-asthma. British Journal of Diseases of the Chest. 1982;76(4):383–389
  25. Spector SL, Tan RA. Effectiveness of montelukast in the treatment of cough variant asthma. Annals of Allergy, Asthma and Immunology. 2004;93(3):232–236
  26. Callaghan B, Teo NC, Clancy L. Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma. Chest. 1992;101(3):787–792
  27. Creticos P, Burk J, Smith L, Comp R, Norman P, Findlay S. The use of twice daily nedocromil sodium in the treatment of asthma. Journal of Allergy and Clinical Immunology. 1995;95(4):829–836
  28. Fink JN, Forman S, Silvers WS, Soifer MM, Tashkin DP, Wilson AF. A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators. Journal of Allergy and Clinical Immunology. 1994;94(3 Pt 1):473–481
  29. Wasserman SI, Furukawa CT, Henochowicz SI, Marcoux JP, Prenner BM, Findlay SR, et al. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. Journal of Allergy and Clinical Immunology. 1995;95(2):541–547
  30. Connolly KC, Peake MD, Halpin DMG, Golightly L, Turbitt ML. Challenging current asthma treatment guidelines: improved control of asthma symptoms with nebulised budesonide in patients with severe asthma receiving continuous oral steroids. Disease Management and Health Outcomes. 2000;7(4):217–225
  31. Ostojic V, Cvoriscec B, Ostojic SB, Reznikoff D, Stipic-Markovic A, Tudjman Z. Improving asthma control through telemedicine: a study of short-message service. Telemedicine Journal and e-Health. 2005 Feb;11(1):28–35
  32. Shioya T, Satake M, Sano M, Kagaya M, Watanabe A, Sato K, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. European Journal of Clinical Pharmacology. 2002;58(3):171–176
  33. Govindan S, Viswanathan S, Vijayasekaran V, Alagappan R. Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytotherapy Research. 2004;18(10):805–809
  34. Eriksson NE, Haglind K, Ewald U. Combined theophylline/beta-agonists maintenance therapy in chronic asthma. European Journal of Respiratory Diseases. 1983 Apr;64(3):172–177
  35. Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma. Journal of Asthma. 2002;39(4):291–297
  36. Simon SW. Symptomatic treatment of asthmatic bronchitis. Journal of the American Geriatric Society. 1960;8:107–111
  37. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respiratory Medicine. 2006;100(9):1623–1632
  38. Dueholm M, Nielsen C, Thorshauge H, Evald T, Hansen NC, Madsen HD, et al. N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study. Respiratory Medicine. 1992;86(2):89–92
  39. Jackson IM, Barnes J, Cooksey P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. Journal of International Medical Research. 1984;12(3):198–206
  40. Engel T, Heinig JH, Madsen O, Hansen M, Weeke ER. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. European Respiratory Journal. 1989;2(10):935–939
  41. Shioya T, Satake M, Kagaya M, Sano MA, Watanabe A, Fukui S, et al. Antitussive effects of the H1-receptor antagonist epinastine in patients with atopic cough (eosinophilic bronchitis). Arzneimittel-Forschung. 2004;54(4):207–212
  42. Volkova LI, Budkova AA, Filonova NN, Khristolyubova EI, Kutuzova EB, Koroleva NV, et al. Efficacy of supplemental anti-inflammatory therapy with fenspiride in chronic obstructive and nonobstructive bronchitis. Clinical Drug Investigation. 2005;25(4):257–264
  43. Repsher LH. Treatment of stable chronic bronchitis with iodinated glycerol: a double-blind, placebo-controlled trial. Journal of Clinical Pharmacology. 1993;33(9):856–860
  44. Petty TL. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. [see comment] Chest. 1990;97(1):75–83
  45. Passeri M, Ippolito L, Valenti G, Denti L, Bernocchi D, Ceresini G. A new twice-daily slow-release theophylline suspension (Teonova Syrup). Clinical experience in broncho-obstructive chronic pathology of the eldery. Clinical Trials Journal. 1988;25(2):93–102
  46. Nicolis FB, Pasquari G. Controlled clinical trials of antitussive agents – experimental evaluation of different methods. Journal of Pharmacology and Experimental Therapeutics. 1962;136(2):183–189
  47. Auffarth B, Postma DS, de Monchy JG, van der Mark TW, Boorsma M, Koeter GH. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax. 1991;46(5):372–377
  48. Smith J, Owen E, Earis J, Woodcock A. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. 2006;117(4):831–835
  49. Giovannini M, Perri G, Rocca A, Spada E. Efficacy and tolerability of domiodol (Mucolitico Maggioni) in long-term treatment of patients with chronic bronchitis. Clinical Trials Journal. 1988;25(3):211–218
  50. Shmelev EI, Kunicina YL. Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease. Clinical Drug Investigation. 2006;26(3):151–159
  51. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. [see comment][erratum appears in Lancet 1998 Jun 27;351(9120):1968] Lancet. 1998;351(9105):773–780
  52. Campbell M, Eliraz A, Johansson G, Tornling G, Nihlen U, Bengtsson T, et al. Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respiratory Medicine. 2005;99(12):1511–1520
  53. Sergysels RAG. A double-masked, placebo-controlled polysomnographic study of the antitussive effects of helicidine. Current Therapeutic Research. 2001;62(1):35–47
  54. Friedman MA. Multicenter study of nebulised bronchodilator solutions in chronic obstructive pulmonary disease. The American Journal of Medicine. 1996;100:1A–39S
  55. Chong CF, Chen CC, Ma HP, Wu YC, Chen YC, Wang TL. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. Emergency Medicine Journal. 2005;22(6):429–432
  56. Zuin R, Palamidese A, Negrin R, Catozzo L, Scarda A, Balbinot M. High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease. Clinical Drug Investigation. 2005;25(6):401–408
  57. Paggiaro PL, Vagaggini B, Di Franco A, Zingoni M, Fano M, Biraghi M. Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease. Respiration. 2006;73(5):603–609
  58. Cattaneo C. Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo. Minerva Medica. 2001;92(4):277–284
  59. D'Elia CSF. Neltenexine versus carbocysteine in the treatment of exacerbations of mild chronic obstructive pulmonary disease: a randomized, controlled, open-label study. Current Therapeutic Research. 2001;62(12):851–861
  60. Fadda G. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol. Minerva Medica. 2001 Aug;92(4):269–275
  61. Todisco T, Trippetti M, Vernelli C, Cardillo G, Jannacci L, Spigarelli E. Effect of nesosteine, a new muco-active agent on mucociliary clearance in bronchitic patients. Clinical Trials Journal. 1988;25(5):315–322
  62. Bellia V, Foresi A, Bianco S, Grassi V, Olivieri D, Bensi G, et al. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH trial). Respiratory Medicine. 2002;96(11):881–889
  63. Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health study. American Journal of Medicine. 1999;106(4):410–416
  64. Thomas P, St. Pierre M, Hidinger K-G. Theophylline blood level and pulmonary function tests utilizing standard and sustained-release theophylline tablets. Current Therapeutic Research. 1984;35(3):331–336
  65. Pizzichini MMM, Pizzichini E, Parameswaran K, Clelland L, Efthimiadis A, Dolovich J, et al. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Canadian Respiratory Journal. 1999;6(4):323–330
  66. Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, et al. Opiate therapy in chronic cough. American Journal of Respiratory and Critical Care Medicine. 2007;175(4):312–315
  67. Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax. 2006 Dec;61(12):1065–1069
  68. Sevelius H, Colmore JP. Objective assessment of antitussive agents in patients with chronic cough. The Journal of New Drugs. 1966 Jul–Aug;6(4):216–223
  69. Vaezi MF, Richter JE, Stasney CR, Spiegel JR, Iannuzzi RA, Crawley JA, et al. Treatment of chronic posterior laryngitis with esomeprazole. The Laryngoscope. 2006 Feb;116(2):254–260
  70. Baldi F, Cappiello R, Cavoli C, Ghersi S, Torresan F, Roda E. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World Journal of Gastroenterology. 2006;12(1):82–88
  71. Kiljander TO, Salomaa ERM, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. European Respiratory Journal. 2000;16(4):633–638
  72. Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. The Laryngoscope. 2001;111:2147–2151
  73. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. American Journal of Gastroenterology. 1999 Nov;94(11):3131–3138
  74. Crimi E, Orefice U, De Benedetto F, Grassi V, Brusasco V. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease. Annals of Allergy, Asthma and Immunology. 1995;74(6):501–508
  75. Bisetti A, Mancini C. Mucolytic activity of erdosteine double blind clinical trial vs placebo. Archivio di Medicina Internazionale. 1995;47(4):89–97
  76. Lillenfield LS, Rose JC, Princiotto JV. Antitussive activity of diphenhydramine in chronic cough. Clinical Pharmacology and Therapeutics. 1976;19(4):421–425
  77. Li J, Zheng JP, Yuan JP, Zeng GQ, Zhong NS, Lin CY. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chinese Medical Journal. 2004;117(6):828–834
  78. Del Donno M, Aversa C, Corsico R, Forsesi A, Grassi V, Malerba M, et al. Efficacy and safety of moguisteine in comparison with dextromethorphan in patients with persistent cough. Drug Investigation. 1994;7(2):93–100
  79. Aquilina R, Bergero F, Noceti P, De Michelis C. Double blind study with neltenexine vs placebo in patients affected by acute and chronic lung diseases. Minerva Pneumologica. 2001;40(2):77–82
  80. Caporalini R, Giosue GL. Neltenexine in lung diseases: an open, randomised, controlled study versus N-acetylcysteine comparison. Minerva Pneumologica. 2001;40(2):57–62
  81. Chernish SM, Kraft B, Lewis G, Howell J. Clinical evaluation of a new antitussive preparation. Annals of Allergy. 1963;21(12):677
  82. Beulcke G. Acebrophylline and theophylline in the treatment of bronchial asthma. An open comparative, randomized study. Acta Therapeutica. 1995;21(2):101–111
  83. Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S. Efficacy of beclomethasone dipropionate HFA 200 μg once daily in chronic obstructive pulmonary disease and bronchial asthma. Journal of International Medical Research. 2007;35(3):361–373
  84. Verver S, Poelman M, Bogels A, Chisholm SL, Dekker FW. Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention study. Family Practice. 1996;13(1):35–40
  85. Chaudhuri R, McMahon AD, Thomson LJ, MacLeod KJ, McSharry CP, Livingston E, et al. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. Journal of Allergy and Clinical Immunology. 2004;113(6):1063–1070
  86. Berthelot J, Weibel MA. Comparative clinical evaluation of the antitussive activity of butamirate citrate linctus (Sinecod) v. a codeine-containing linctus (Netux). Clinical Trials Journal. 1990;27(1):50–57
  87. Mann JS, Clement P, Sheridan AQ, Soryal I, Fairfax AJ, Holgate ST. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study. Journal of Allergy and Clinical Immunology. 1985;76(1):83–90
  88. Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database of Systematic Reviews. 2006;18(4):CD004823
  89. Jan RL, Wang JY, Huang MC, Tseng SM, Su HJ, Liu LF. An internet-based interactive telemonitoring system for improving childhood asthma outcomes in Taiwan. Telemedicine Journal and e-Health. 2007 Jun;13(3):257–268
  90. Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care in Cancer. 2009 Apr;17(4):437–444
  91. Chung KF. Chronic cough: future directions in chronic cough: mechanisms and antitussives. Chronic Respiratory Disease. 2007;4(3):159–165
  92. Irwin RS. Assessing cough severity and efficacy of therapy in clinical research: aCCP evidence-based clinical practice guidelines. Chest. 2006 Jan;129(Suppl. 1):232S–237S
  93. Pavord ID, Chung KF. Management of chronic cough. Lancet. 2008 Apr 19;371(9621):1375–1384
  94. Palombini BC, Villanova CA, Araujo E, Gastal OL, Alt DC, Stolz DP, et al. A pathogenic triad in chronic cough: asthma, postnasal drip syndrome, and gastroesophageal reflux disease. Chest. 1999 Aug;116(2):279–284

PII: S0954-6111(10)00080-6

doi: 10.1016/j.rmed.2010.02.010

Respiratory Medicine
Volume 104, Issue 7 , Pages 934-944 , July 2010

Article Tools